NCT00211315View on ClinicalTrials.gov

Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.)

PHASE2CompletedINTERVENTIONAL

Enrollment

4

Participants

Timeline

Start Date

March 31, 2002

Study Completion Date

March 31, 2007

Conditions

Coat's Disease

Interventions

DRUG

anecortave acetate

Trial Locations (1)

10021

Manhattan Eye, Ear & Throat Hospital, New York

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Alcon Research

INDUSTRY

lead

Manhattan Eye, Ear & Throat Hospital

OTHER